rs569851503
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM1BP4_Moderate
The NM_000100.4(CSTB):c.29A>C(p.Gln10Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000118 in 1,529,408 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q10E) has been classified as Uncertain significance.
Frequency
Consequence
NM_000100.4 missense
Scores
Clinical Significance
Conservation
Publications
- Unverricht-Lundborg syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, G2P, Orphanet, Labcorp Genetics (formerly Invitae)
- keratolytic winter erythemaInheritance: AD Classification: MODERATE Submitted by: PanelApp Australia
- genetic developmental and epileptic encephalopathyInheritance: AR Classification: MODERATE Submitted by: ClinGen
- autosomal recessive hypohidrotic ectodermal dysplasiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CSTB | NM_000100.4 | c.29A>C | p.Gln10Pro | missense_variant | Exon 1 of 3 | ENST00000291568.7 | NP_000091.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CSTB | ENST00000291568.7 | c.29A>C | p.Gln10Pro | missense_variant | Exon 1 of 3 | 1 | NM_000100.4 | ENSP00000291568.6 | ||
| CSTB | ENST00000640406.1 | c.29A>C | p.Gln10Pro | missense_variant | Exon 1 of 2 | 2 | ENSP00000492672.1 | |||
| CSTB | ENST00000675996.1 | n.90A>C | non_coding_transcript_exon_variant | Exon 1 of 3 | ||||||
| CSTB | ENST00000639959.1 | c.-5A>C | upstream_gene_variant | 5 | ENSP00000492123.1 |
Frequencies
GnomAD3 genomes AF: 0.0000658 AC: 10AN: 152016Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000158 AC: 2AN: 126306 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000581 AC: 8AN: 1377284Hom.: 0 Cov.: 31 AF XY: 0.00000442 AC XY: 3AN XY: 679436 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152124Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74366 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:3
- -
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
- -
Inborn genetic diseases Uncertain:1
The c.29A>C (p.Q10P) alteration is located in exon 1 (coding exon 1) of the CSTB gene. This alteration results from a A to C substitution at nucleotide position 29, causing the glutamine (Q) at amino acid position 10 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Progressive myoclonic epilepsy Uncertain:1
This sequence change replaces glutamine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 10 of the CSTB protein (p.Gln10Pro). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with CSTB-related conditions. ClinVar contains an entry for this variant (Variation ID: 193045). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at